Italy looks to New Britain General Hospital for Expertise on Endometriosis
New Britain [January 10 2006] -
Three members of the Italian Senate arrived at New Britain General Hospital Tuesday on a fact-finding mission to learn about a disease that can greatly impact women’s fertility and day-to-day lives.
The senators (see below for names) came to learn about endometriosis, an often painful condition in which the uterus repeatedly produces excess lining, which can also hinder a woman’s ability to become pregnant. The senators met with Anthony Luciano, M.D., head of the Center for Fertility and Women’s Health at the hospital, and an international authority on endometriosis. In addition, Congresswoman Nancy Johnson was on hand to meet the visiting dignitaries and discussed differences between the healthcare systems of the United States and Italy.
“Endometriosis is a chronic, non-curable disease that can impact a woman’s quality of life in many ways,” Luciano explained. “Because it can be so painful, it can affect their roles as spouses, employees, and their overall ability to function in society.”
Often the disease begins when a young woman begins menstruating, and continues until she reaches menopause. While there is no cure for endometriosis, there are several effective treatments, and Dr. Luciano has been actively involved in international research centered on treating the disease.
The Italian government is particularly interested in endometriosis because of the system of socialized medicine in that country. Two years ago, the European Congress voted to designate endometriosis as a “disease of society,” which gives it priority in their echelon of medical care, Luciano explained. If Italy decides to do so as well, women in that country will get treated more quickly and may receive additional social support. In addition, physicians who treat the disease will receive a better reimbursement.
Editor’s note: The senators are Laura Bianconi, Monica Beltoni, and Rossana Lidia Boldi.
Contact: Helayne Lightstone, 860-224-5470 or 860-224-5695
HCC Corporate Communications
(860) 224-5695 •
Fax (860) 224-5779